论文部分内容阅读
血栓栓塞性疾病（Ｔｈｒｏｍｂｏｅｍｂｏｌｉｃｄｉｓｅａｓｅｓ，ＴＥＤ） ,是遗传性和获得性危险因素共同作用的结果。目前 ,在许多国家 ,ＴＥＤ仍然是一种高发生率及高死亡率的疾病。分子生物学技术的发展 ,为从基因水平研究血栓形成提供了技术支持。近年来 ,许多学者开始
Thromboembolic disorders (TEDs) are the result of a combination of genetic and acquired risk factors. TED is still a disease with high incidence and high mortality rate in many countries at present. The development of molecular biology technology provides technical support for the study of thrombosis at the gene level. In recent years, many scholars began